The CCT5 Gene Neuropathy Hereditary Sensory with Spastic Paraplegia Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the CCT5 gene. These mutations are known to cause a rare genetic disorder characterized by hereditary sensory neuropathy coupled with spastic paraplegia. This condition affects the nervous system, leading to sensory loss and muscle stiffness, particularly in the lower limbs, significantly impacting mobility and quality of life.
This genetic test is pivotal for early diagnosis and management of the condition, enabling healthcare professionals to tailor treatments and interventions that can alleviate symptoms and improve patient outcomes. Performed with a sample of the patient's DNA, the test scrutinizes the CCT5 gene for specific genetic alterations that are indicative of the disorder.
The cost of the CCT5 Gene Neuropathy Hereditary Sensory with Spastic Paraplegia Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the sophisticated genetic analysis required to detect the presence of CCT5 mutations, offering invaluable insights for affected individuals and their families. Early diagnosis through this test can facilitate timely therapeutic strategies, potentially slowing the progression of symptoms and enhancing the patient's life quality.
The PNPLA2 Gene Neutral Lipid Storage Disease with Myopathy Genetic Test is a specialized diagnostic assessment performed to identify mutations in the PNPLA2 gene, which are responsible for causing Neutral Lipid Storage Disease with Myopathy (NLSDM). This rare genetic disorder is characterized by the accumulation of neutral lipids in the body's cells, leading to a variety of symptoms including muscle weakness, cardiomyopathy, and liver dysfunction. The test is crucial for confirming the diagnosis, understanding the disease's progression, and guiding treatment decisions.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive analysis of the PNPLA2 gene. By examining the specific genetic makeup of an individual, healthcare providers can identify mutations that lead to NLSDM, offering insights into the severity of the condition and potential therapeutic approaches.
The cost of the PNPLA2 Gene Neutral Lipid Storage Disease with Myopathy Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the intricate process of genetic analysis, the expertise required to interpret the results accurately, and the significant value it provides in managing the condition effectively. Patients seeking this test can expect a reliable service that employs advanced genetic testing technologies to deliver precise and actionable findings.
The NPC1 gene Niemann-Pick Disease Type C1 genetic test is a diagnostic tool used to detect mutations in the NPC1 gene, which are responsible for Niemann-Pick disease type C1 (NPC1), a rare and potentially fatal genetic disorder. This condition interferes with the body's ability to transport and metabolize cholesterol and other fats, leading to their accumulation in various organs, including the liver, spleen, and brain. Symptoms can include difficulty moving, seizures, and cognitive decline, among others, and can vary widely from person to person.
The test involves analyzing the patient's DNA, extracted from a blood sample, to look for mutations in the NPC1 gene that are known to cause the disease. It is particularly valuable for individuals with a family history of NPC1 or those who exhibit symptoms suggestive of the condition, as early diagnosis can significantly influence management and treatment options.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the NPC1 gene test is priced at 4400 AED. DNA Labs UAE employs state-of-the-art technology and highly skilled professionals to ensure accurate and reliable test results, providing crucial information for the diagnosis, treatment planning, and genetic counseling of affected individuals and their families.
The GTPBP2 gene plays a significant role in the neurological disorder known as Neurodegeneration with Brain Iron Accumulation (NBIA). NBIA is characterized by the accumulation of iron in the brain, particularly in the basal ganglia, leading to a range of movement disorders and neurodegenerative symptoms. Mutations in the GTPBP2 gene have been identified as one of the genetic causes behind certain forms of this disorder. These mutations can disrupt normal cellular functions, leading to the progressive degeneration of nervous tissue and the hallmark iron accumulation.
To diagnose and understand the specific genetic underpinnings of NBIA in patients suspected of having GTPBP2-related neurodegeneration, genetic testing is essential. DNA Labs UAE offers a comprehensive genetic test targeting the GTPBP2 gene to identify mutations that may be responsible for the condition. The test is crucial for accurate diagnosis, which can guide treatment decisions and genetic counseling.
The cost of the GTPBP2-related genetic test at DNA Labs UAE is 4400 AED. This investment covers the meticulous process of DNA analysis to detect the presence of mutations in the GTPBP2 gene. By opting for this test, patients and their families can gain valuable insights into the genetic basis of their condition, opening the door to targeted therapies and interventions that can improve quality of life and manage symptoms more effectively.
The BRAT1 Gene Neurodevelopmental Disorder with Cerebellar Atrophy and with or Without Seizures Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE. This test is designed to identify mutations in the BRAT1 gene, which have been associated with a rare neurodevelopmental disorder. This condition is characterized by cerebellar atrophy, which can lead to significant developmental delays, motor skill impairments, and in some cases, seizures. The genetic test aims to provide conclusive evidence of the presence of BRAT1 mutations, facilitating early diagnosis and enabling tailored management strategies for affected individuals. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately detect and interpret BRAT1 gene mutations. By opting for this test, families and healthcare providers can gain crucial insights into the genetic underpinnings of this neurodevelopmental disorder, paving the way for better-informed treatment and support decisions.
The ADAM22 gene plays a significant role in the proper development and function of the nervous system. Mutations in this gene have been linked to a range of neurodevelopmental disorders, which can manifest as cognitive impairments, developmental delays, and sometimes, seizures or motor dysfunction. Recognizing the importance of accurate diagnosis for individuals showing symptoms related to ADAM22 gene mutations, DNA Labs UAE offers a specialized genetic test designed to identify alterations in the ADAM22 gene that could be responsible for such neurodevelopmental conditions.
This test is a critical tool for clinicians and families seeking answers to complex neurodevelopmental issues, providing essential information that can guide treatment plans and support services. The testing process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing techniques to identify any mutations in the ADAM22 gene.
The cost of the ADAM22 Related Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the ADAM22 gene and interpret the results. For families and individuals facing the challenges of neurodevelopmental disorders, this test offers a pathway to understanding the genetic underpinnings of their condition, potentially opening up new avenues for targeted interventions and support.
APC2 Gene Neurodevelopmental Disorder is a rare genetic condition characterized by developmental delays, intellectual disabilities, and potentially other neurological or physical abnormalities. This condition is caused by mutations in the APC2 gene, which plays a crucial role in the regulation of cell growth and division, as well as in the development and function of the nervous system. Individuals with mutations in this gene may exhibit a wide range of symptoms, including difficulties in learning, speech delays, motor skills challenges, and sometimes, physical anomalies or behavioral issues.
To diagnose this condition, the APC2-Related Genetic Test is a critical tool. This test specifically looks for mutations in the APC2 gene that are known to cause the neurodevelopmental disorder. By analyzing an individual's DNA, the test can confirm the presence of these genetic alterations, providing a definitive diagnosis that can guide further treatment and management plans.
The APC2-Related Genetic Test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED. This comprehensive test is performed by skilled geneticists and laboratory technicians using state-of-the-art technology to ensure accurate and reliable results. For families and individuals facing symptoms suggestive of the APC2 Gene Neurodevelopmental Disorder, this test offers a crucial step towards understanding the condition and planning for the future. It's important for those interested to consult with healthcare professionals to understand the implications of the test and to receive appropriate genetic counseling before and after the testing process.
CNTNAP4 Gene Neurodevelopmental Disorder is a rare genetic condition linked to the CNTNAP4 gene, which plays a significant role in the development and function of the nervous system. This disorder can manifest through a variety of symptoms, including developmental delays, intellectual disabilities, and possibly autism spectrum disorders. Given the complexity of neurodevelopmental disorders, identifying a genetic basis like a mutation in the CNTNAP4 gene can provide crucial insights for diagnosis, management, and treatment.
To aid in the diagnosis of this condition, DNA Labs UAE offers a specialized genetic test targeting the CNTNAP4 gene. This test is designed to detect mutations within the gene that may be responsible for neurodevelopmental disorders. The testing process involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for genetic abnormalities associated with the CNTNAP4 gene.
The cost of the CNTNAP4 Related Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full process of sample collection, genetic analysis, and the provision of a comprehensive report detailing the findings. The report not only offers insights into the patient's genetic condition but also provides valuable information that can guide future treatment and management strategies.
By opting for this genetic test, individuals suspected of having neurodevelopmental disorders linked to the CNTNAP4 gene can gain a clearer understanding of their condition. This can be particularly beneficial for families seeking answers to developmental concerns in their children, enabling them to access tailored support and interventions at an early stage.
The CROCC Gene Neurodevelopmental Disorder is a rare genetic condition that is associated with mutations in the CROCC gene. This gene plays a crucial role in the proper development and function of the nervous system. Mutations or alterations in the CROCC gene can lead to various neurodevelopmental challenges, including cognitive impairments, developmental delays, and sometimes physical abnormalities.
To diagnose this condition, a specific genetic test is available that analyzes the CROCC gene for any mutations that might be responsible for the disorder. This test is crucial for confirming the diagnosis, understanding the condition better, and aiding in the development of a personalized treatment plan for the affected individual.
In the United Arab Emirates, this specialized genetic test can be conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the CROCC Related Genetic Test at DNA Labs UAE is 4400 AED. This price includes the cost of the test procedure, analysis, and a comprehensive report detailing the findings. The test is performed under the guidance of experienced geneticists and utilizes the latest in genetic testing technology to ensure accurate and reliable results.
For families and individuals dealing with neurodevelopmental challenges, this test provides a valuable tool for diagnosis and planning for the future. It is an important step towards understanding the genetic basis of the disorder and exploring potential interventions or supports that can improve the quality of life for those affected.
The FRMPD4 gene is associated with a neurodevelopmental disorder that can affect cognitive, social, and motor development. This condition is linked to mutations in the FRMPD4 gene, which plays a crucial role in synaptic formation and neuronal communication, essential for normal brain development and function. Individuals with mutations in this gene may present a variety of symptoms, including developmental delays, learning disabilities, and possibly autism spectrum disorders.
To diagnose this condition, a specific genetic test targeting the FRMPD4 gene can be conducted. DNA Labs UAE offers this specialized genetic testing service to identify mutations in the FRMPD4 gene that may be responsible for neurodevelopmental disorders. The test is a critical step for families seeking answers to developmental concerns in their loved ones, providing essential information that can guide treatment and intervention strategies.
The cost of the FRMPD4 related genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of mutations in the FRMPD4 gene. By confirming a diagnosis, this test can be a cornerstone in the management and understanding of the individual's condition, enabling tailored support and interventions that can significantly improve quality of life.
